Cargando…
551. Convalescent plasma early in disease course improves survival in COVID-19
BACKGROUND: Convalescent plasma (CP) has been described as a potential therapy for coronavirus disease 2019 (COVID-19). Given paucity of data, we sought to describe characteristics of CP recipients in survivors and non-survivors. METHODS: We conducted retrospective review of electronic medical recor...
Autores principales: | Nauriyal, Varidhi, Shallal, Anita, Vahia, Amit T, Samuel, Linoj, Tibbetts, Robert, Lopez-Plaza, Ileana, Ramesh, Mayur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777732/ http://dx.doi.org/10.1093/ofid/ofaa439.745 |
Ejemplares similares
-
402. Spontaneous pneumothorax in COVID-19
por: Tariq, Zain, et al.
Publicado: (2020) -
11. Missed Vaccine Opportunities During the COVID-19 Pandemic
por: Shallal, Anita, et al.
Publicado: (2020) -
444. Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Southeast Michigan
por: Vahia, Amit T, et al.
Publicado: (2020) -
669. Rapid Molecular Testing of Sputum for Identification of Pulmonary Tuberculosis: Impact on Duration of Respiratory Isolation
por: Acosta, Tommy J Parraga, et al.
Publicado: (2020) -
328. Universal PCR Testing- Is It Worth It?
por: Birk, Navina K, et al.
Publicado: (2022)